Skip to main content
Akebia Therapeutics, Inc. logo

Akebia Therapeutics, Inc. — Investor Relations & Filings

Ticker · AKBA ISIN · US00972D1054 LEI · 549300CBQEHMKEEGNX42 US Manufacturing
Filings indexed 851 across all filing types
Latest filing 2024-09-10 Regulatory Filings
Country US United States of America
Listing US AKBA

About Akebia Therapeutics, Inc.

https://akebia.com/

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company that develops and commercializes therapeutics for patients with kidney disease. The company's mission is to improve the lives of people impacted by renal conditions by developing novel treatments that have the potential to set new standards of care. Akebia has two FDA-approved products, including Vafseo, an oral treatment for anemia in adult patients on dialysis. Its capabilities range from research and clinical development through to commercialization.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2024
Regulatory Filings
2024-09-10 English
Regulatory Filings 2024
Regulatory Filings
2024-09-09 English
S-3
Registration Form
2024-09-03 English
10-Q
Interim / Quarterly Report Q2 2024
2024-08-08 English
8-K
Regulatory Filings
2024-08-08 English
8-K
Regulatory Filings
2024-07-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.